Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Dermatology and Therapy|March 18, 2025
Brodalumab for Plaque Psoriasis in the Canadian Real-World Setting: A Retrospective Cohort Analysis of up to 4 YearsVeronique Gaudet, Irina Turchin, Charles W Lynde, et al.
Journal of Cutaneous Medicine and Surgery|October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in AdultsCharles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Dermatology and Therapy|August 8, 2024
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK InhibitorsMark G Kirchhof, Vimal H Prajapati, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|September 17, 2016
Review of Systemic Treatment Options for Adult Atopic DermatitisMelinda Gooderham, Charles W Lynde, Kim Papp, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Treatment of Impetigo and Antimicrobial ResistanceLawrence A Schachner, Charles W Lynde, Leon H Kircik, et al.
Journal of Cutaneous Medicine and Surgery|February 12, 2019
Treating to Target(s) With Interleukin-17 InhibitorsCharles W Lynde, Jennifer Beecker, Jan Dutz, et al.
Rheumatology and Therapy|April 10, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN)Dara K Shahrokh, Ronald B Vender, Charles W Lynde, et al.
Journal of Drugs in Dermatology : JDD|January 18, 2017
Development of a Clinical Pathway for Atopic Dermatitis Patients: A Case-Based ApproachLyn C Guenther, Anneke Andriessen, Charles W Lynde, et al.
The Journal of Investigative Dermatology|March 14, 2017
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled StudyRobert Bissonnette, François Harel, James G Krueger, et al.
JAMA Dermatology|March 9, 2016
Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical TrialsApril W Armstrong, Charles W Lynde, Sandy R McBride, et al.
Pageof 8